Summary & Overview
HCPCS G9401: Missing Documentation of Genotype-Informed Treatment Discussion
HCPCS Level II code G9401 denotes the absence of documented discussion between a clinician and a patient regarding genotype-informed treatment choices, including risks, benefits, evidence of effectiveness, and patient preferences. Nationally, this code signals gaps in documentation that can affect quality measurement, care coordination, and genomic medicine integration across health systems. Clear documentation of shared decision-making for genotype-driven treatment is increasingly important as precision medicine expands.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Payer approaches to documentation and performance measurement vary; some payers tie documentation requirements to quality programs or prior authorization processes while others use medical record review for compliance and audit purposes.
Readers will find an overview of what G9401 represents, why it matters for clinical documentation and quality reporting, and what to look for in payer policies and benchmarking. The publication covers common modifiers and associated administrative elements, where available, and summarizes clinical context for genotype-informed treatment discussions. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code G9401 indicates that there is no documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient covering all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment. This code represents a documentation deficiency related to genotype-informed treatment counseling.
Service Type: Genotype-informed treatment counseling documentation review
Typical Site of Service: Outpatient clinic or ambulatory care setting where genotype-guided treatment decisions would be discussed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult undergoing pharmacogenomic testing or genotype-informed therapy planning for a chronic condition such as major depressive disorder, atrial fibrillation, or oncologic targeted therapy. The patient presents to an outpatient specialty clinic (e.g., psychiatry, cardiology, oncology) after genetic test results are available. The clinical workflow includes review of the genotype report by the ordering clinician, discussion of treatment options tailored to the patient’s genotype (for example, alternative antidepressants, anticoagulant dosing adjustments, or targeted cancer therapies), explanation of risks and benefits, presentation of the evidence base supporting genotype-directed choices, and documentation of the patient’s preferences and informed consent. The billing code G9401 applies when the medical record does not contain documentation that this comprehensive discussion occurred between the physician or other qualified healthcare professional and the patient covering genotype-appropriate treatment choices, risks/benefits, evidence of effectiveness, and patient preferences toward treatment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when services are substantially greater than usual, documented and justified in the record |